Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p87 has 87 genes in the original annotation. Currently, there are 71 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
5599	MAPK8	JNK \| JNK-46 \| JNK1 \| JNK1A2 \| JNK21B1/2 \| PRKM8 \| SAPK1 \| SAPK1c	mitogen-activated protein kinase 8	10q11.22
818	CAMK2G	CAMK \| CAMK-II \| CAMKG	calcium/calmodulin-dependent protein kinase II gamma	10q22
10718	NRG3	HRG3 \| pro-NRG3	neuregulin 3	10q23.1
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
6199	RPS6KB2	KLS \| P70-beta \| P70-beta-1 \| P70-beta-2 \| S6K-beta2 \| S6K2 \| SRK \| STK14B \| p70(S6K)-beta \| p70S6Kb	ribosomal protein S6 kinase B2	11q13.2
5058	PAK1	PAKalpha	p21 protein (Cdc42/Rac)-activated kinase 1	11q13.5-q14.1
867	CBL	C-CBL \| CBL2 \| FRA11B \| NSLL \| RNF55	Cbl proto-oncogene, E3 ubiquitin protein ligase	11q23.3
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
2065	ERBB3	ErbB-3 \| HER3 \| LCCS2 \| MDA-BF-1 \| c-erbB-3 \| c-erbB3 \| erbB3-S \| p180-ErbB3 \| p45-sErbB3 \| p85-sErbB3	erb-b2 receptor tyrosine kinase 3	12q13
6655	SOS2	NS9	SOS Ras/Rho guanine nucleotide exchange factor 2	14q21
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
56924	PAK6	PAK5	p21 protein (Cdc42/Rac)-activated kinase 6	15q14
399694	SHC4	RaLP \| SHCD	SHC (Src homology 2 domain containing) family member 4	15q21.1-q21.2
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
145957	NRG4	HRG4	neuregulin 4	15q24.2
5579	PRKCB	PKC-beta \| PKCB \| PRKCB1 \| PRKCB2	protein kinase C beta	16p11.2
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
5336	PLCG2	APLAID \| FCAS3 \| PLC-IV \| PLC-gamma-2	phospholipase C gamma 2	16q24.1
23533	PIK3R5	F730038I15Rik \| FOAP-2 \| P101-PI3K \| p101	phosphoinositide-3-kinase regulatory subunit 5	17p13.1
1398	CRK	CRKII \| p38	v-crk avian sarcoma virus CT10 oncogene homolog	17p13.3
6776	STAT5A	MGF \| STAT5	signal transducer and activator of transcription 5A	17q11.2
2064	ERBB2	CD340 \| HER-2 \| HER-2/neu \| HER2 \| MLN 19 \| NEU \| NGL \| TKR1	erb-b2 receptor tyrosine kinase 2	17q12
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
5578	PRKCA	AAG6 \| PKC-alpha \| PKCA \| PRKACA	protein kinase C alpha	17q24.2
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
5609	MAP2K7	JNKK2 \| MAPKK7 \| MEK \| MEK 7 \| MKK7 \| PRKMK7 \| SAPKK-4 \| SAPKK4	mitogen-activated protein kinase kinase 7	19p13.3-p13.2
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
8503	PIK3R3	p55 \| p55-GAMMA \| p55PIK	phosphoinositide-3-kinase regulatory subunit 3	1p34.1
5293	PIK3CD	APDS \| IMD14 \| P110DELTA \| PI3K \| p110D	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	1p36.2
2475	MTOR	FRAP \| FRAP1 \| FRAP2 \| RAFT1 \| RAPT1 \| SKS	mechanistic target of rapamycin	1p36.2
27	ABL2	ABLL \| ARG	ABL proto-oncogene 2, non-receptor tyrosine kinase	1q25.2
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
57144	PAK7	PAK5	p21 protein (Cdc42/Rac)-activated kinase 7	20p12
6714	SRC	ASV \| SRC1 \| c-SRC \| p60-Src	SRC proto-oncogene, non-receptor tyrosine kinase	20q12-q13
5335	PLCG1	NCKAP3 \| PLC-II \| PLC1 \| PLC148 \| PLCgamma1	phospholipase C gamma 1	20q12-q13.1
1399	CRKL	-	v-crk avian sarcoma virus CT10 oncogene homolog-like	22q11.21
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
7039	TGFA	TFGA	transforming growth factor alpha	2p13
8440	NCK2	GRB4 \| NCKbeta	NCK adaptor protein 2	2q12
2066	ERBB4	ALS19 \| HER4 \| p180erbB4	erb-b2 receptor tyrosine kinase 4	2q33.3-q34
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
868	CBLB	Cbl-b \| Nbla00127 \| RNF56	Cbl proto-oncogene B, E3 ubiquitin protein ligase	3q13.11
2932	GSK3B	-	glycogen synthase kinase 3 beta	3q13.3
4690	NCK1	NCK \| NCKalpha \| nck-1	NCK adaptor protein 1	3q21
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
5062	PAK2	PAK65 \| PAKgamma	p21 protein (Cdc42/Rac)-activated kinase 2	3q29
685	BTC	-	betacellulin	4q13.3
5602	MAPK10	JNK3 \| JNK3A \| PRKM10 \| SAPK1b \| p493F12 \| p54bSAPK	mitogen-activated protein kinase 10	4q22.1-q23
1950	EGF	HOMG4 \| URG	epidermal growth factor	4q25
817	CAMK2D	CAMKD	calcium/calmodulin-dependent protein kinase II delta	4q26
2549	GAB1	-	GRB2 associated binding protein 1	4q31.21
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
1839	HBEGF	DTR \| DTS \| DTSF \| HEGFL	heparin binding EGF like growth factor	5q23
9542	NRG2	DON1 \| HRG2 \| NTAK	neuregulin 2	5q31.2
815	CAMK2A	CAMKA	calcium/calmodulin-dependent protein kinase II alpha	5q32
1026	CDKN1A	CAP20 \| CDKN1 \| CIP1 \| MDA-6 \| P21 \| SDI1 \| WAF1 \| p21CIP1	cyclin-dependent kinase inhibitor 1A	6p21.2
1956	EGFR	ERBB \| ERBB1 \| HER1 \| NISBD2 \| PIG61 \| mENA	epidermal growth factor receptor	7p12
816	CAMK2B	CAM2 \| CAMK2 \| CAMKB	calcium/calmodulin-dependent protein kinase II beta	7p14.3-p14.1
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
1978	EIF4EBP1	4E-BP1 \| 4EBP1 \| BP-1 \| PHAS-I	eukaryotic translation initiation factor 4E binding protein 1	8p12
3084	NRG1	ARIA \| GGF \| GGF2 \| HGL \| HRG \| HRG1 \| HRGA \| MST131 \| MSTP131 \| NDF \| NRG1-IT2 \| SMDF	neuregulin 1	8p12
4609	MYC	MRTL \| MYCC \| bHLHe39 \| c-Myc	v-myc avian myelocytomatosis viral oncogene homolog	8q24.21
5747	PTK2	FADK \| FAK \| FAK1 \| FRNK \| PPP1R71 \| p125FAK \| pp125FAK	protein tyrosine kinase 2	8q24.3
53358	SHC3	N-Shc \| NSHC \| RAI \| SHCC	SHC (Src homology 2 domain containing) transforming protein 3	9q22.1
25	ABL1	ABL \| JTK7 \| bcr/abl \| c-ABL \| c-ABL1 \| p150 \| v-abl	ABL proto-oncogene 1, non-receptor tyrosine kinase	9q34.1
2002	ELK1	-	ELK1, ETS transcription factor	Xp11.2
5063	PAK3	MRX30 \| MRX47 \| OPHN3 \| PAK-3 \| PAK3beta \| bPAK \| beta-PAK	p21 protein (Cdc42/Rac)-activated kinase 3	Xq23